Objective: The scheme provides long term capital appreciation by investing in equity/equity
related instruments of the companies in the Pharmaceuticals, Healthcare and Allied
sectors in India.
The Scheme does not guarantee/indicate any returns. There can be no
assurance that the schemes’ objectives will be achieved.
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is an Equity - Sector - Healthcare fund. The fund was launched inJul 11, 2019. Its risk level is . The NAV of the fund as onJul 15, 2025 is ₹31.20. Its expense ratio is 2.45 %. The fund has an AUM of ₹814.18 Cr.The fund is managed byDhaval Shah,Dhaval Joshi.
The minimum initial investment is ₹1000 in Lumpsum mode.